Call for Abstract
3rd International Conference on Genetic and Protein Engineering
(10 Plenary Forums - 1 Event), will be organized around the theme “Protein Engineering : Exploring the patterns of life.”
Protein Engineering 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Protein Engineering 2017
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Protein Engineering is the process of creating helpful or profitable proteins and it research happens into the comprehension of collapsing and acknowledgment for protein plan standards. Analysts will have further point by point learning on In vitro development of proteins, Aspects of Biocatalysis, Advances in designing proteins for biocatalysis, Protein Engineered Biomaterials and many subjects. Computational Protein Engineering, Constructing practical biocatalysts and Growth of manufactured science are likewise normally utilized themes as a part of protein designing. Protein engineering business sector is estimated to develop at a CAGR of 15.7% to reach $1,463.0 million by 2020. There are very nearly 3000 individuals from 60-65 colleges in USA working for Protein Engineering and there are a few meetings & workshops like biomolecular designing gatherings, sub-atomic cell science workshops, protein engineering meetings, antibody engineering 2015 are conducting throughout the year globally.
- Track 1-1Protein engineering design and selection
- Track 1-2Retrometabolic drug design
- Track 1-3Plant and Human Genetics
- Track 1-4Membrane proteins
- Track 1-5Protein folding
- Track 1-6Growth of synthetic biology
- Track 1-7Aspects of biocatalysis
- Track 1-8Constructing functional biocatalysts
- Track 1-9Advances in engineering proteins for biocatalysis
- Track 1-10In vitro evolution of proteins
- Track 1-11Computational protein engineering
Genetic engineering, also called genetic adjustment, is the immediate control of a living being's genome utilizing biotechnology. It is an arrangement of innovations used to change the genetic makeup of cells, comprising the exchange of genes within and across species boundaries to produce improved or novel organisms. Genetic adjustment, Genome investigation, Genetic designing strategies, Molecular docking & computational transformative science are the diverse points secured under Genetic Engineering.
- Track 2-1Genetic modification
- Track 2-2Molecular Markers
- Track 2-3Genetic and molecular basis of crop improvement
- Track 2-4Plant and Human Genetics
- Track 2-5Molecular Genetics and Microbiology
- Track 2-6Plant Biotechnology, Plant Genetics and its developments
- Track 2-7Current challenges in modeling cellular metabolism
- Track 2-8Machine learning in molecular systems biology
- Track 2-9Genetic engineering techniques
- Track 2-10Genome analysis
- Track 2-11Applications of genomics
- Track 2-12Molecular docking and computational evolutionary biology
- Track 2-13Transgenics
Enzyme Engineering is the application of genetic engineering techniques to enzyme technology. There are a number of properties which may be improved or altered by genetic engineering including the production and kinetics of the enzyme, Structure of the enzymes, De novo design, Intersection of protein engineering and next-generation sequencing, Rational alteration of enzyme function, Combinatorial Enzyme Engineering & Enzyme and biosensor Engineering. There are almost 4000+ people from 75 universities in USA working for Enzyme Engineering.
- Track 3-1Structure of the enzymes
- Track 3-2De novo design
- Track 3-3Intersection of protein engineering and next-generation sequencing
- Track 3-4Rational alteration of enzyme function
- Track 3-5Combinatorial enzyme engineering
- Track 3-6Enzyme and biosensor Engineering
Antibodies are exclusive in their high affinity and specificity for a binding partner, a quality that has made them one of the most useful molecules for biotechnology and biomedical applications. The field of Antibody Engineering has changed quickly in the past 10 years, fueled by Engineering bi-specific antibodies, Phage and Yeast Display of Antibodies, Bi specific antibodies & combination therapy and Antibodies for cancer therapy. While human antibody gene libraries and synthetic antibody libraries are also prominent subject in Antibody Engineering. There are almost 4000+ people from 75 universities in USA working for Antibody Engineering.
- Track 4-1Engineering bi-specific antibodies
- Track 4-2Phage and yeast display of antibodies
- Track 4-3Bi specific antibodies & combination therapy
- Track 4-4Antibodies for cancer therapy
- Track 4-5Human antibody gene libraries
- Track 4-6Synthetic antibody libraries
Recombinant protein production & purification, Protein expression and purification, CHI protein and Protein electrophoresis are the topics covered in the protein purification. Protein purification is a series of processes planned to isolate one or a few proteins from a complex mixture, usually cells, tissues or whole organisms. Protein purification is vital for the characterization of the function, structure and interactions of the protein of interest.
- Track 5-1Recombinant protein production and purification
- Track 5-2Protein expression and purification
- Track 5-3CHI protein
- Track 5-4Protein electrophoresis
Protein folding is the physical process by which a protein chain acquires its native 3-dimensional structure, a conformation that is usually biologically functional, in an expeditious and reproducible manner. From last few years, Researchers are keeping their effort in tackling the mystery of different mechanisms, driving forces, and processes occurring in protein folding.
- Track 6-1Protein folding
- Track 6-2Mechanisms of folding
- Track 6-3Protein folding and processing
- Track 6-4Driving force of protein folding
- Track 6-5Computational methods in protein folding
Protein crystallography visualizes protein structures at the atomic level and helps in understanding the protein function with the help of very high-resolution microscopy. Protein Crystallography has been highly used in designing novel drugs that target a particular protein or an enzyme that can be used for industrial processes.
- Track 7-1Protein crystallography
- Track 7-2X Ray crystallography
- Track 7-3Crystal storage and processing
- Track 7-4Principles of protein crystallography
The availability of growth factors and the increasing knowledge base concerning the bone regeneration with modern techniques like recombinant signaling molecules, solid free form fabrication of scaffolds, synthetic cartilage, Electrochemical deposition, spinal fusion & ossification are new generated techniques for tissue-engineering applications. Biomedical Engineering research is the foremost research which includes Nano applications to biomedical sciences and tissue engineering, Nano medicines, Cell interactions with Nano particles, Revolutionary opportunities and future possibility of nanotechnology, Bio-nanotechnology Biomedical Nanotechnology, Tissue Growing Nanostructures, Nano-Mechanisms for Molecular Systems, Nano-Bio-Computing, Biomedical Application of Nanoparticles and Functional Nanomaterials and Devices for Biomedical Engineering.
- Track 8-1Biomaterials in biomedical engineering
- Track 8-2Protein-biomaterial interactions
- Track 8-3Biomaterials design and technology
- Track 8-4Protein Engineered Biomaterials
Cancer Genomics is the study of genetic changes in charge of disease, utilizing genome sequencing and bioinformatics. Cancer genomics is to enhance tumour treatment and results lies in figuring out which sets of qualities and quality communications effect diverse subsets of growths. Global Cancer Genome Consortium (ICGC) is a deliberate exploratory association that gives a discussion to combined effort among the world's driving growth and genomic specialists. The subjects like malignancy hereditary qualities, protein markers, Cancer Functional Genomics and Epigenomics, Bioinformatics & Systems Biology of Cancer and Big Data and Genome Medicine are secured in this taking after track
- Track 9-1Cancer genetics
- Track 9-2Protein markers in cancer cells
- Track 9-3Bioinformatics & systems biology of cancer
- Track 9-4Cancer functional genomics & epigenomics
- Track 9-5Translation & clinical impact of cancer genomics
- Track 9-6Big data & genome medicine
There are lot of applications used for protein but mostly we are having good research and number of companies and projects for the following applications Protein modification, targeting and degradation, Protein identification & validation, Protein profiling studies in diabetes, Imaging mass spectrometry and profiling of tissue sections, Designer proteins and Protein Dietary Supplements. Protein Engineering market is $56 billion in 2012 to $168 billion in 2017, a compound annual growth rate (CAGR) of 10.9% from 2012 through 2017. There are almost 3000 people from 60-65 universities in USA working for Genetic and Protein Engineering.
- Track 10-1Protein identification and validation
- Track 10-2Protein modification, targeting and degradation
- Track 10-3Chemical genetic methodology
- Track 10-4ECM proteins and protein fragments
- Track 10-5Advances in cell and gene therapy
- Track 10-6Novel methods in regenerative medicine
- Track 10-7Molecular Breeding for sustainable Agriculture
- Track 10-8Plant Breeding
Regenerative medicine is a division of translational research in tissue engineering and molecular biology which deals with the process of replacing, engineering or regenerating human cells, tissues or organs to reinstate or establish normal function. The latest developments in the regenerative medicine research involves advances in cell and gene therapy and stem cell research, molecular therapy, dental & craniofacial regeneration. Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are proficient of restoring the functionality of cells and tissues. The global regenerative medicine industry market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during prediction period (2014 - 2020). Small molecules and biologics segment holds prominent market share in the overall regenerative medicine technology market and is expected to grow at a CAGR of 18.9% during the forecast period. As per the market analysis the research in this felid is highly concentrated in Europe which is interim as a platform to conduct central European conference on regenerative medicine.
- Track 11-1Advances in cell and gene therapy
- Track 11-2Novel methods in regenerative medicine
- Track 11-3ECM proteins and protein fragments
Transcriptome analysis and Gene Expression is the first and the important topics to be discussed. While going in depth of the subject, it is necessary to understand Transcriptome as Key Players in Gene Expression. For that we must know the basics knowledge of how the central dogma works. This can be achieved by gaining proper knowledge about functioning of mRNA, tRNA and rRNA. Gene expression analysis experimentations can focus on a subset of relevant target genes. The location of gene and relative distances between genes on a chromosome can be determined through Sequence mapping. Even in the lack of the reference genome, transcriptome can be created using de novo transcriptome assembly method. Globally around thousands of Universities and institutes are carrying research on gene expression and transcriptome analysis.
- Track 12-1Transcriptomes of stem cells and cancer cells
- Track 12-2Role of microRNA (miRNA) and small interfering RNA (siRNA
- Track 12-3Functioning of mRNA, tRNA and rRNA
- Track 12-4Cellular differentiation and carcinogenesis
- Track 12-5Serial analysis of gene expression
- Track 12-6Transcriptomic and proteomic profiling
- Track 12-7Transcription of gene
Pharmacogenomics & Pharmacoproteomics is the study of the use of genetics in drug response and provided DNA for genomes. It deals with the influence of acquired and inherited genetic variation on drug response in patients by Protein aggregation & stability in biopharmaceuticals, New discoveries in genomic targets, Various drug responses due to genetic polymorphisms, Drug dosage formulations, Drug safety and its efficiency and Membrane transport proteins. There are almost 3000 people from 60-65 universities in USA working for Proteomics. The NIH Pharmacogenomics Research Network (PGRN) is a network of scientists funding to PharmGKB since 2000.
- Track 13-1Protein aggregation and stability in biopharmaceuticals
- Track 13-2New discoveries in genomic targets
- Track 13-3Various drug responses due to genetic polymorphisms
- Track 13-4Drug dosage formulations
- Track 13-5Drug safety and its efficacy
- Track 13-6Membrane transport proteins
Protein Expression contains of the stages after DNA has been transcribed to messenger RNA (mRNA) from the process of Optimizing protein expression, Prokaryotic and Eukaryotic systems, Fusion protein therapeutics ,Cell line & cell culture development& Protein microarray studies. Recombinant production of proteins is one of the most powerful techniques used in the Life Sciences. There are nearly 3000 people from 60-65 universities in USA working for Protein Expression. The Oxford Protein Production Facility-UK (OPPF-UK) is a UK core facility for protein production located in the Research Complex at Harwell. The project has recently received additional funding of £2.3M from the MRC to provide a range of highly specialized technologies incorporating robotic systems, for the high throughput expression, purification & crystallization of recombinant proteins
- Track 14-1Optimizing protein expression
- Track 14-2Prokaryotic and eukaryotic systems
- Track 14-3Cell line & cell culture development
- Track 14-4Fusion protein therapeutics
- Track 14-5Protein microarray studies
Proteomics is an developing field that has been highly enabled by the human genome project. Proteins are the products of genes, the machinery of the cells in our bodies. Protein mass spectrometry refers to the utilization of mass spectrometry to the study of proteins. Mass spectrometry is an important emerging method for the characterization of proteins. Two-dimensional gel electrophoresis can be used to generate cellular protein maps which give a quantitative and qualitative picture of the proteome. Mass spectrometry is the method of choice for the rapid large-scale identification of these proteomes and their alterations. Proteogenomics uses mass spectrometry data to experimentally validate gene products and to assist in the process of genome annotation & comparison. There are almost 3000 people from 60-65 universities in USA working for Proteomics. Research Awards in the amount of $35,000 each are presented annually. Two awards are fully sponsored by Thermo Scientific and Waters Corporation.
- Track 15-1Electrospray ionization mass spectrometry (ESI-MS)
- Track 15-2Matrix-Assisted laser desorption (MALDI-TOF-MS)
- Track 15-3Liquid chromatography mass spectrometry (LC-MS)
- Track 15-4Multidimensional protein identification technology
- Track 15-5Protein identification and validation
Protein Biomarkers, Recombinant protein drugs, Protein gold standards, Protein expression services and market analysis, Fusion protein therapeutics are the various applications and sources for Protein Therapeutics & Market Analysis.Protein therapeutics already have a significant role in almost every field of medicine, but this role is still only in its infancy.
- Track 16-1Protein Biomarkers and its Diagnostics
- Track 16-2Recombinant protein drugs
- Track 16-3Protein gold standards
- Track 16-4Protein expression services and market analysis
- Track 16-5Fusion protein therapeutics
Molecular modelling is a technique for originating, representing and manipulating the structures and reactions of molecules, and those properties that are dependent on these three dimensional structure, Drug design, frequently referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target
- Track 17-1Molecular Modelling: Principles And Applications
- Track 17-2Molecular graphics
- Track 17-3Monte Carlo method and Molecular design software
- Track 17-4Drug development
- Track 17-5Retrometabolic drug design